MedPath

A Clinical Study on the Combined Effect of Ayaskriti and Navaka Guggulu - Ayurvedic Medicine in the Management of Madhumeha (Diabetes Mellitus Type 2)

Recruiting
Conditions
Madhumeha (Diabetes mellitus type 2)
Registration Number
CTRI/2017/05/008680
Lead Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
Brief Summary

Madhumeha is considered as one of the ashtamahagad as caused by the involvement of tridosha and dashadushyas. As Madhumeha is krichrasadya or yapya, a good control and effective management is ultimate aim to reduce the risk of the development of further complications. It is quite difficult to formulate a single drug effective on all clinical manifestations of Madhumeha.

With this background there is a need for drugs from herbal source which is effective, with least adverse effects and palatable so that patient can use the drug lifelong to control Madhumeha. The study focus on assessing the combined effect of Ayuskriti and Navaka Guggulu, a preparation mentioned for the management of Madhumeha. The combined effect of these drugs and properties like kledahara, medohara, dravashoshana, ushnavirya, and katuvipakan would be beneficial in the management of Madhumeha. Ayaskritiis an arishta yoga which has the combination of Asanadigana having Kashaya-Tiktapradhanarasa, katuvipaka, and ushnavirya. Similarly Navaka Guggulu contains triyushana and triphala which is deepaniya and pachaniya, laghu and rookshan and guggulu with medohara properti. The combination of these drugs will be helpful in the Dhosaprathyanika and Vyadiprathyanika Chikitsa of Madhumeha. And also after thorough review of research in Ayurveda other thesis data base did not yield any result in relation to the combination of Ayaskriti and Navaka Guggulu.

 In the preset study, open label single arm clinical trial at OPD or IPD basis would be done with pre and post-test design for the included 30 patients. Pre diagnosed and freshly diagnosed patients will be taken.  Than  Ayaskriti 20 ml and Navaka Gugguku 500 mg thrice daily in the morning and night will be administered after food with ushnodaka as anupana for the 30 days. After the 30 days again the blood investigations will be done to rule out the effect of drugs administered. Hence the entire treatment will be completed in 30  days.

The patient will be assessed on the 1st day and 30th day with investigations like FBS, PPBS, Blood routine, lipid profile and urine routine. Assessment would be done based on subjective and objective parameters and would also be monitored for Adverse Drug Reactions or Adverse Drug Effects or other concurrent illness.

The collected data will be tabulated and analyzed using Statistical Package for Social Sciences (SPSS) version 20.Statistical tests like paired t test, repeated measure anova will be done.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Diabetes mellitus Type 2 with Fasting Blood Sugar: 126-180mg/dl, or Post Prandial Blood Sugar: 180-230mg/dl or HbA1c 6.5-8 2.
  • Pre-detected and freshly detected cases.
  • Patients taking or not taking any other ayurvedic drugs or any allopathic anti-diabetic drugs.
  • Age group between 30-70yrs will be included in the study.
  • Informed written consent will be obtained from the included patients.
Exclusion Criteria
  • Diabetes mellitus Type 2 associated other systemic disorders or complications like congestive cardiac failure, chronic renal failure, cerebrovascular disease.
  • Diabetes mellitus Type 2 patients who are on insulin injection.
  • Gestational diabetes, pregnant and the lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in Fasting blood glucose levels and Post prandial blood glucose levels30 days
Secondary Outcome Measures
NameTimeMethod
Reduction in signs and symptoms symp(diabetes mellitus type 2)30 days

Trial Locations

Locations (1)

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan

🇮🇳

Hassan, KARNATAKA, India

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
🇮🇳Hassan, KARNATAKA, India
Dr Rukmani Sharma
Principal investigator
08172256460
rukurmgshrma@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.